TSNDF

0.30029.93%
ID

Ira Duarte

Independent Director

Ms. Ira Duarte has been an Independent Director of TerrAscend Corp. since December 2, 2022. She had been the Chief Financial Officer of Veloxis Pharmaceuticals, Inc. since October 2018 until 2023. She serves as Chief Financial Officer at Heron Therapeutics, Inc. since June 2023 and serves as its Executive Vice President since June 2023. Ms. Duarte had been Chief Financial Officer of Veloxis Pharmaceuticals A/S since October 31, 2018 until 2023. Ms. Duarte served as an Interim Chief Financial Officer of Veloxis Pharmaceuticals A/S since September 24, 2018 until October 31, 2018 and served as its Vice-President of Finance since February 2016. Ms. Duarte served as the Corporate Controller at BioDelivery Sciences, Inc. from 2014 to 2016. Prior to joining Veloxis, Ms. Duarte served as a Senior Director of Corporate Finance for Chiesi USA, Inc. She served as Principal Accounting Officer of Cornerstone Therapeutics Inc. since April 1, 2010 and served as its Director of Accounting, Financial Planning & Analysis. Ms. Duarte served as a Director of Accounting of Cornerstone Therapeutics Inc. from June 2009 to July 1, 2010. Before transitioning to a corporate role, Ms. Duarte held various roles from Staff to Senior Manager at Ernst & Young, managing financial statement audits, SEC filings and IPOs for clients. Ms. Duarte holds a BS in Accounting from Florida Atlantic University.

Positions